ES2166406T3 - Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina. - Google Patents

Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.

Info

Publication number
ES2166406T3
ES2166406T3 ES95935280T ES95935280T ES2166406T3 ES 2166406 T3 ES2166406 T3 ES 2166406T3 ES 95935280 T ES95935280 T ES 95935280T ES 95935280 T ES95935280 T ES 95935280T ES 2166406 T3 ES2166406 T3 ES 2166406T3
Authority
ES
Spain
Prior art keywords
insulin
patients
dependent
control
gastric emptying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95935280T
Other languages
English (en)
Inventor
Rochelle Hanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of ES2166406T3 publication Critical patent/ES2166406T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

USO DE UN COMPUESTO DE LA FORMULA (1) O SAL FISIOLOGICA DE LA MISMA EN LA FABRICACION DE UN AGENTE TERAPEUTICO PARA EL TRATAMIENTO DE LAS AFECCIONES DIABETICAS DEPENDIENTES NO INSULINICAMENTE PRECOCES.
ES95935280T 1994-10-14 1995-10-13 Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina. Expired - Lifetime ES2166406T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9420747A GB9420747D0 (en) 1994-10-14 1994-10-14 1,5 benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
ES2166406T3 true ES2166406T3 (es) 2002-04-16

Family

ID=10762854

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95935280T Expired - Lifetime ES2166406T3 (es) 1994-10-14 1995-10-13 Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.

Country Status (10)

Country Link
EP (1) EP0785787B1 (es)
JP (1) JPH10511931A (es)
AT (1) ATE210446T1 (es)
AU (1) AU3736195A (es)
DE (1) DE69524622T2 (es)
DK (1) DK0785787T3 (es)
ES (1) ES2166406T3 (es)
GB (1) GB9420747D0 (es)
PT (1) PT785787E (es)
WO (1) WO1996011691A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2239293A1 (en) 1995-12-11 1997-06-19 New England Medical Center Hosptials, Inc. Assay for and uses of peptide hormone receptor ligands
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
EP1123928A4 (en) * 1998-10-20 2005-02-16 Takeda Pharmaceutical 1,5-BENZODIAZEPINE COMPOUNDS, PROCESS FOR PRODUCING THE SAME, AND MEDICAMENT
EP3414239A2 (en) 2016-02-05 2018-12-19 Denali Therapeutics Inc. Inhibitors of receptor-interacting protein kinase 1
PL3552017T3 (pl) 2016-12-09 2022-08-08 Denali Therapeutics Inc. Związki użyteczne jako inhibitory RIPK1
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187154A (en) * 1990-12-13 1993-02-16 Board Of Regents, The University Of Texas System Diagnosis and treatment of humans with diabetes or at risk to develop diabetes
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
JPH10511931A (ja) 1998-11-17
WO1996011691A1 (en) 1996-04-25
PT785787E (pt) 2002-04-29
DE69524622D1 (de) 2002-01-24
EP0785787B1 (en) 2001-12-12
AU3736195A (en) 1996-05-06
DK0785787T3 (da) 2002-03-11
DE69524622T2 (de) 2002-08-08
EP0785787A1 (en) 1997-07-30
ATE210446T1 (de) 2001-12-15
GB9420747D0 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
PH23014A (en) Novel insulin derivatives,their use and pharmaceutical agents for the treatment of diabetes mellitus
CA2029596A1 (en) Medicaments containing r-a-lipoic acid
FI20010683A (fi) Menetelmä aineenvaihdunnallisten häiriöiden, erityisesti diabeteksen tai diabetekseen liittyvän sairauden tai tilan hoitamiseksi
TNSN00206A1 (en) Method for treating diabetes
AU3300600A (en) Use of stabilised oligonucleotides for preparing a medicine with antitumour activity
BR0015294A (pt) Método para tratamento da diabetes
AU536196B2 (en) Chromium acetylacetonate dietary and pharmaceutical agent
ES2032896T3 (es) Procedimiento para la preparacion de cristales mixtos a base de insulina y derivados de insulina.
GB2223168B (en) Pharmaceutical composition comprising inositoltrisphosphate for the treatment of complications of diabetes
ES2166406T3 (es) Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.
NZ332105A (en) Medicaments including human growth hormone for the treatment of type II diabetes and metabolic syndrome
ES2163531T3 (es) Carboxilatos de aminoguanidina para el tratamiento de diabetes mellitus no insulinodependiente.
PE104499A1 (es) Composicion farmaceutica de tiazolidindiona e insulina para el tratamiento de la diabetes
KR890004690A (ko) 당뇨병의 치료를 위한 베자피브레이드의 용도
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030346A1 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
GB0205898D0 (en) Treatment of type I diabetes mellitus
ES2042533T3 (es) Medio para la administracion en hipoglucemia.
FR2390165A1 (fr) Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant
Davico et al. The Autobiography of Edward Jarvis (1803-1884)
NZ273710A (en) use of ketoconazole or a derivative which is a cortisol synthesis inhibitor in medicaments for treatment of type II diabetes
IT8902513A0 (it) Materasso flessibile, particolarmente per uso terapeutico.
RU92015326A (ru) Средство для лечения конъюнктивита

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 785787

Country of ref document: ES